Found: 10
Select item for more details and to access through your institution.
First cases of European bat lyssavirus type 1 in Iberian serotine bats: Implications for the molecular epidemiology of bat rabies in Europe.
- Published in:
- PLoS Neglected Tropical Diseases, 2018, v. 12, n. 3, p. 1, doi. 10.1371/journal.pntd.0006290
- By:
- Publication type:
- Article
Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents.
- Published in:
- Journal of Infectious Diseases, 2024, v. 229, n. 6, p. 1812, doi. 10.1093/infdis/jiad411
- By:
- Publication type:
- Article
Identification of a Cluster of HIV-1 Controllers Infected with Low Replicating Viruses.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0077663
- By:
- Publication type:
- Article
Comparative phylogeography and asymmetric hybridization between cryptic bat species.
- Published in:
- Journal of Zoological Systematics & Evolutionary Research, 2019, v. 57, n. 4, p. 1004, doi. 10.1111/jzs.12318
- By:
- Publication type:
- Article
COVID‐19 vaccine effectiveness against hospitalization due to SARS‐CoV‐2: A test‐negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain.
- Published in:
- Influenza & Other Respiratory Viruses, 2022, v. 16, n. 6, p. 1014, doi. 10.1111/irv.13026
- By:
- Publication type:
- Article
Coinfection and Superinfection in Patients with Long-Term, Nonprogressive HIV-1 Disease.
- Published in:
- Journal of Infectious Diseases, 2007, v. 196, n. 6, p. 895, doi. 10.1086/520885
- By:
- Publication type:
- Article
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
- Published in:
- Eurosurveillance (15607917), 2024, v. 29, n. 13, p. 1, doi. 10.2807/1560-7917.ES.2024.29.13.2300403
- By:
- Publication type:
- Article
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID- 19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 47, p. 1, doi. 10.2807/1560-7917.es.2023.28.47.2300186
- By:
- Publication type:
- Article
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 47, p. 1, doi. 10.2807/1560-7917.ES.2023.28.47.2300186
- By:
- Publication type:
- Article
Going beyond serology for stratifying the risk of CMV infection in transplant recipients.
- Published in:
- Reviews in Medical Virology, 2019, v. 29, n. 1, p. N.PAG, doi. 10.1002/rmv.2017
- By:
- Publication type:
- Article